Anti-Cancer Compound Library
Explore 500+ anti-cancer compounds for oncology drug discovery.
This ready-to-screen library supports cell-based assays and mechanism-specific screens.
Now available through Tebubio.
Unlock focused screening and faster validation with 500+ bioactive small molecules
In oncology research, speed, selectivity, and translational relevance are key when identifying promising drug candidates. Whether you're targeting apoptosis, angiogenesis, DNA repair, or cell cycle regulation, having access to high-quality chemical libraries is essential to generating reliable screening data.
At Tebubio, we’re proud to introduce the Anti-Cancer Compound Library from TargetMol—a carefully curated collection of over 500 small molecules with well-documented anti-cancer properties. This ready-to-screen set is optimized for high-throughput screening (HTS), mechanism-of-action studies, hit validation, and lead optimization, helping researchers across Europe streamline their oncology workflows.
Why This Library? A Focused Resource for Oncology Discovery
The compounds in this library are selected based on extensive pharmacological data and validated mechanisms of action across various cancer types. It includes:
- FDA-approved drugs with established safety and efficacy profiles
- Clinical candidates and investigational agents in various stages of development
- Pathway-specific modulators, targeting critical processes like apoptosis, autophagy, EMT, immune checkpoint inhibition, PI3K/AKT, MAPK, and more
Each molecule is provided in a ready-to-use format, making the library ideal for phenotypic screening, target validation, and combination strategy development in cancer models.
Designed for Experimental Versatility
Researchers can easily integrate this compound set into a wide range of assay platforms:
- Cell viability and proliferation assays
- Reporter gene assays and high-content imaging
- Synergy testing with immuno-oncology agents or mRNA therapeutics
- Pathway analysis in organoids or 3D tumor spheroids
The library supports both hypothesis-driven screening and exploratory discovery approaches, offering broad chemical diversity while staying focused on cancer-related targets.
Your Workflow, Accelerated
By choosing this pre-validated compound library, researchers can save time and resources typically spent on compound sourcing, QC validation, and structural annotation. Each molecule is supplied with:
- High chemical purity
- Verified structural information
- Documented pharmacological activity
- Easy-to-search compound metadata
Diana Perrier, Marketing Manager
Marketing Team at Tebubio
"Combined with Tebubio’s local support and integrated Contract Research Services, the Anti-Cancer Compound Library becomes more than just a collection—it’s a strategic asset for accelerating oncology drug discovery."
Name goes here
Position goes here
Description goes here
-
References
Article content created by Tebubio using courtesy materials provided by TargetMol.
All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
Ready to take the next step?
Not sure which product suits your research best? Our scientific team is here to help! From product selection to Contract Research Services (CRS), we provide expert guidance tailored to your research project needs.